TP53 and cancer: This is particularly evident in inherited forms of cancer, such as hereditary retinoblastoma (RB gene) or Li-Fraumeni syndrome, in which patients with a mutation in the TP53 gene have a 50% risk of developing different tumors (Bougeard et al., 2015).